MALAYBALAY CITY, Bukidnon — The Department of Agriculture – Northern Mindanao (DA-10) is enhancing its support for indigenous peoples (IPs) in Bukidnon province through various agricultural programs and services

On January 9, under its Kabuhayan at Kaunlaran para sa Kababayang Katutubo (4K) program, the agency turned over PhP480,000 worth of carabaos to IP groups in Impasugong town.

The beneficiaries include the Ananaso Pigbuligaan Farmers’ Association (APFA) of Sitio Ananaso, Brgy. Dumalaguing, and the Kapunongan sa mga Mag-uuma sa Ulayanon (KAMAU) of Sitio Ulayanon, Brgy. Kalabugao.

Each group received six carabaos (five female, one male), which the IP farmer-beneficiaries withdrew from DA-10’s Northern Mindanao Agricultural Crops and Livestock Research Complex. (pr)

DOH-CHDNM to Introduce Shorter TB Treatment Regimen

CAGAYAN DE ORO CITY (January 10, 2025) – The Department of Health-Center for Health Development Northern Mindanao (DOH-CHDNM) is set to reduce tuberculosis (TB) treatment duration from the traditional six months to four months.

DOH-CHDNM will launch a capacity-building program for health workers in 2025, focusing on a shorter TB regimen for patients aged three months to 16 years.

During a press conference on Universal Health Care Day, Dr. Wellaflor Kindom-Brito, head of the infectious diseases cluster at DOH-CHDNM, announced the implementation of a six-month short regimen for drug-resistant tuberculosis.

Brito added that oral tuberculosis treatment will be the only option. “We expect that with advancements in medication, patient adherence to treatment will improve, reducing instances of patients stopping or failing to follow up on treatment,” she said.

DOH data indicate that tuberculosis deaths in Region 10 reached 285 in 2020, 250 in 2021, 295 in 2022, and 390 in 2023. In the third quarter of 2024 alone, there were 375 TB deaths in the region.

Brito noted that the rising TB mortality rate is partly due to increasing TB cases. Poor health-seeking behavior also contributes to the higher mortality rate, as patients often seek medical help too late when their condition has worsened. Additionally, poor adherence to medication exacerbates the issue.

“Some patients experience adverse reactions to the medication, leading them to stop treatment altogether, while others move residences, interrupting their treatment,” Brito explained. She emphasized that TB treatment, unlike typical antibiotic regimens, lasts from six months to two years.

Brito expressed optimism that the new treatment changes would enhance TB patients’ adherence to medication. (Jasper Marie O. Rucat/PIA-10)